Abstract

As normal cells progress toward malignancy, they must switch to an angiogenic phenotype to attract the nourishing vasculature that they depend on for their growth. In cultured fibroblasts from Li-Fraumeni patients, this switch was found to coincide with loss of the wild-type allele of the p53 tumor suppressor gene and to be the result of reduced expression of thrombospondin-1 (TSP-1), a potent inhibitor of angiogenesis. Transfection assays revealed that p53 can stimulate the endogenous TSP-1 gene and positively regulate TSP-1 promoter sequences. These data indicate that, in fibroblasts, wild-type p53 inhibits angiogenesis through regulation of TSP-1 synthesis.

Keywords

AngiogenesisThrombospondin 1ThrombospondinTransfectionAngiogenesis inhibitorPhenotypeBiologyCancer researchEndogenySuppressorGeneFibroblastWild typeCell biologyChemistryGeneticsIn vitroEndocrinology

MeSH Terms

AllelesCellsCulturedFibroblastsGene Expression RegulationGenesp53HumansLi-Fraumeni SyndromeMembrane GlycoproteinsNeovascularizationPathologicPhenotypePromoter RegionsGeneticThrombospondinsTransfection

Affiliated Institutions

Related Publications

Fibroblasts in cancer

Tumours are known as wounds that do not heal - this implies that cells that are involved in angiogenesis and the response to injury, such as endothelial cells and fibroblasts, h...

2006 Nature reviews. Cancer 4355 citations

Publication Info

Year
1994
Type
article
Volume
265
Issue
5178
Pages
1582-1584
Citations
1446
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1446
OpenAlex
36
Influential
1069
CrossRef

Cite This

Kristina M. Dameron, Olga V. Volpert, Michael A. Tainsky et al. (1994). Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1. Science , 265 (5178) , 1582-1584. https://doi.org/10.1126/science.7521539

Identifiers

DOI
10.1126/science.7521539
PMID
7521539

Data Quality

Data completeness: 81%